Found: 6
Select item for more details and to access through your institution.
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 29, doi. 10.1159/000530950
- By:
- Publication type:
- Article
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 629, doi. 10.1159/000517393
- By:
- Publication type:
- Article
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2631, doi. 10.1007/s00262-022-03185-6
- By:
- Publication type:
- Article
Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 2014, doi. 10.3390/cancers14082014
- By:
- Publication type:
- Article
Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4325, doi. 10.3390/cancers13174325
- By:
- Publication type:
- Article
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2355, doi. 10.3390/v14112355
- By:
- Publication type:
- Article